Voriconazole incorporated nanofiber formulations for topical application: preparation, characterization and antifungal activity studies against Candida species
- 7 January 2020
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Development and Technology
- Vol. 25 (4) , 440-453
Abstract
In this study, voriconazole incorporated polyvinyl alcohol/sodium alginate electrospun nanofibers were produced and, then crosslinked with glutaraldehyde for topical antifungal treatment. The nanofibers were characterized in terms of fiber size, surface morphology and compatibility between drug-polymer and polymer-polymer using scanning electron microscopy, atomic force microscopy, attenuated total reflection-fourier transform infrared spectroscopy and high pressure liquid chromatography. After optimization studies, in vitro drug release, skin penetration and deposition studies were performed using Franz diffusion cells. Antifungal activities of the nanofiber formulations against Candida albicans, Candida tropicalis and Candida parapysilosis strains were evaluated using susceptibility test and subsequently time-kill study was performed against Candida albicans. The cytotoxicity study was performed using 4-succinate dehydrogenase viability assay on mouse fibroblast cell line. The release rate of voriconazole from crosslinked nanofibers was slower than that of non-crosslinked nanofibers and Higuchi kinetic model best fitted to the in vitro release data of both of formulations. Voriconazole deposited in deeper skin layers from nanofiber formulations was higher than that of the control formulation (voriconazole solution in propylene glycol (1% (w/v)). According to the susceptibility and time-kill studies, all of the nanofiber formulations showed antifungal activity against Candida albicans with confirming no cytotoxicity on mouse fibroblast cells.Keywords
This publication has 56 references indexed in Scilit:
- CandidaInfections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal AgentsBioMed Research International, 2013
- Hp--CD-VoriconazoleIn SituGelling System for Ocular Drug Delivery:In Vitro, Stability, and Antifungal Activities AssessmentBioMed Research International, 2013
- Poly(vinyl alcohol)/sodium alginate/layered silicate based nanofibrous mats for bacterial inhibitionCarbohydrate Polymers, 2013
- In Vitro Susceptibility of Candida Species to Four Antifungal Agents Assessed by the Reference Broth Microdilution MethodThe Scientific World Journal, 2013
- Cell adhesion and proliferation enhancement by gelatin nanofiber scaffoldsJournal of Bioactive and Compatible Polymers, 2011
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth MicrodilutionJournal of Clinical Microbiology, 2011
- Ophthalmic antimicrobial therapy in the horseEquine Veterinary Education, 2009
- Molecular organization of the lipid matrix in intact Stratum corneum using ATR-FTIR spectroscopyBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Innovative Strategies for Enhancing Topical and Transdermal Drug DeliveryThe Open Drug Delivery Journal, 2007
- Voriconazole Concentration in Human Aqueous Humor and Plasma during Topical or Combined Topical and Systemic Administration for Fungal KeratitisAntimicrobial Agents and Chemotherapy, 2007